rosiglitazone has been researched along with Brain Emboli in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allahtavakoli, M; Pourshanazari, A; Roohbakhsh, A; Shabanzadeh, A | 1 |
1 other study(ies) available for rosiglitazone and Brain Emboli
Article | Year |
---|---|
Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
Topics: Animals; Behavior, Animal; Blood Coagulation; Brain; Cerebral Infarction; Dimethyl Sulfoxide; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hypnotics and Sedatives; Intracranial Embolism; Neuroprotective Agents; PPAR gamma; Rats; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Stroke; Thiazolidinediones | 2007 |